Serous-exudative retinal detachment occurring in the setting of posterior scleritis represents a distinct clinical presentation where the retina separates due to fluid accumulation driven by underlying scleral inflammation — rather than a primary retinal tear or break.
This protocol applies to patients with serous-exudative retinal detachment in whom posterior scleritis has been identified as the causative condition. In this setting, identifying and treating the underlying cause is the central principle of management — the retinal detachment itself is a consequence of the active scleral inflammatory process.
Management is directed at controlling the underlying posterior scleritis. The approach involves systemic anti-inflammatory therapy — the full structured regimen, including agent selection, sequencing, and dosing, is available in the complete protocol.
DOI: 10.1016/S1060-135X(98)90029-X